Functional polymorphisms in the promoter regions of MMP2 and MMP3 are not associated with melanoma progression
Open Access
- 24 October 2007
- journal article
- Published by Springer Nature in Journal of Negative Results in BioMedicine
- Vol. 6 (1) , 9
Abstract
Background: The matrix metalloproteinases (MMPs) are enzymes that cleave various components of the extracellular matrix (ECM) and basement membranes. MMPs are expressed in melanocytes and their overexpression has been linked to tumor development, progression and metastasis. At the genetic level, the following functional promoter polymorphisms are known to modify the gene transcription: -1306 C/T and -735 C/T in the MMP2 gene, and -1171 5A/6A in the MMP3 gene. Functional polymorphisms in MMP genes' promoter regions may modulate the risk for melanoma progression.Methods: We evaluated MMP2 and MMP3 germline polymorphisms in a group of 1002 melanoma patients using PCR-based methods, including fragment size analysis and melting temperature profiles. Two-sided Chi-Square, Cochran-Armitage tests for trend, Fisher's exact tests, and Kendall's Tau tests were performed to evaluate the associations between genotype and various clinical and epidemiologic factors. Multivariate analyses were conducted using logistic regression, adjusting for known melanoma confounders such as age, sex, phenotypic index, moles, freckles, and race. Survival estimates were computed using the Kaplan-Meier method and differences in survival were assessed using the log rank test.Results: All genotypes were in Hardy-Weinberg equilibrium. After adjustment for age, sex and phenotypic characteristics of melanoma risk, no significant associations were identified with the clinical, pathological, and epidemiological variables studied. The melting profile for MMP2 -735 C/T identified a new change in one sample. A new PCR-amplification followed by direct sequencing confirmed a heterozygote G to A substitution at position -729.Conclusion: This study does not provide strong evidence for further investigation into the role of the MMP2 and MMP3 variants in melanoma progression.Keywords
This publication has 17 references indexed in Scilit:
- Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancerCarcinogenesis, 2005
- Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma StudyCarcinogenesis, 2005
- No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinomaLung Cancer, 2005
- Functional Haplotypes in the Promoter of Matrix Metalloproteinase-2 Predict Risk of the Occurrence and Metastasis of Esophageal CancerCancer Research, 2004
- Control of melanoma progression by various matrikines from basement membrane macromoleculesCritical Reviews in Oncology/Hematology, 2004
- Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesionsCancer, 2002
- Matrix metalloproteinases: they're not just for matrix anymore!Current Opinion in Cell Biology, 2001
- Identification of Novel, Functional Genetic Variants in the Human Matrix Metalloproteinase-2 GeneJournal of Biological Chemistry, 2001
- Matrix Metalloproteinases in Human MelanomaJournal of Investigative Dermatology, 2000
- Progression of Coronary Atherosclerosis Is Associated with a Common Genetic Variant of the Human Stromelysin-1 Promoter Which Results in Reduced Gene ExpressionJournal of Biological Chemistry, 1996